IP Library › Granted Patent US 12,636,387
Granted Patent B2
US 12,636,387 · App. 17/698,348 · Granted May 26, 2026

Systems and methods for creating custom brachytherapy carriers

Inventors: Heidi Cole (Phoenix, AZ); David Brachman (Phoenix, AZ); John Baker (Gilbert, AZ); Adam Turner (Phoenix, AZ)
Assignee: GT MEDICAL TECHNOLOGIES, INC.
A61K51/1262A61K51/08A61N5/1001A61N5/1007A61N5/1014B29C33/3835B29C33/3842B29C64/393B33Y50/00A61N2005/101A61N2005/1024A61N5/103B29L2031/7546B33Y80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,636,387
App. No.
17/698,348
Granted
May 26, 2026
Kind
B2
Abstract

Custom radioactive seed carriers are fabricated pre-operatively and/or intra-operatively to more precisely match carrier specification of a radiation treatment plan for a particular patient. One or more carrier specification component, such as a 3D printer, injection molding system, machining component, or bioprinter, may be utilized to create the custom carrier.

Claims (49)

1 . A method comprising:

receiving treatment specifications including at least a tumor cavity size and shape and a radiation dose;

determining a carrier configuration based on the treatment specifications, the carrier configuration indicating, for at least a first custom carrier, a carrier shape and a radioactive seed quantity;

based at least on the carrier configuration, generating the first custom carrier using one or more custom carrier components, the one or more custom carrier components including one or more of a 3D printer, injection molding system, machining component, or bioprinter;

based at least on the radioactive seed quantity indicated in the carrier configuration, inserting one or more radioactive seeds into the first custom carrier according to a seed position indicated in the treatment specifications; and

providing the first custom carrier for implantation into a cavity of a particular mammal.

2 . The method of claim 1 , wherein the carrier configuration further includes radioactive seed strength and radioactive seed orientation.

3 . The method of claim 1 , wherein the first custom carrier has a thickness between one and seven centimeters.

4 . A method comprising:

receiving treatment specifications including at least a tumor cavity size and shape and a radiation dose;

determining a carrier configuration based on the treatment specifications, the carrier configuration indicating, for at least a first custom carrier, a carrier shape and a radioactive seed quantity;

based at least on the carrier configuration, determining a custom mold configuration;

providing the custom mold configuration to a 3D printer;

forming the first custom carrier using a custom mold created by the 3D printer;

based at least on the radioactive seed quantity indicated in the carrier configuration, inserting one or more radioactive seeds into the first custom carrier;

lyophilizing the first custom carrier;

sterilizing the first custom carrier; and

initiating transport of the first custom carrier to an implantation location, wherein the first custom carrier is specially designed for implantation into a cavity of a particular mammal.

5 . The method of claim 4 , wherein the first custom carrier is rectangular.

6 . The method of claim 4 , wherein the first custom carrier is spherical.

7 . The method of claim 6 , wherein the first custom carrier has a diameter between one and seven centimeters.

8 . The method of claim 4 , wherein the first custom carrier is shaped and sized to correspond to the tumor cavity.

9 . The method of claim 4 , wherein the first custom carrier is configured for separation into a plurality of smaller custom carriers for implantation into the cavity of the particular mammal.

10 . The method of claim 9 , wherein said separation is performed with a cutting device.

11 . The method of claim 9 , wherein the first custom carrier includes one or more markings indicating locations where the first custom carrier is configured for separation.

12 . The method of claim 4 , wherein said lyophilizing the first custom carrier reduces an area of the first custom carrier by more than twenty percent.

13 . The method of claim 12 , wherein the first custom carrier is configured to expand upon hydration.

14 . The method of claim 13 , wherein said hydration is provided by saline or a bodily fluid.

15 . The method of claim 4 , wherein the carrier configuration further includes radioactive seed strength and radioactive seed orientation.

16 . A method comprising:

receiving treatment specifications including at least a tumor cavity size and shape and a radiation dose;

determining a desired carrier configuration based on the treatment specifications, the desired carrier configuration indicating, for at least a first custom carrier, a carrier shape and a radioactive seed quantity;

determining a closest fit carrier already fabricated and available for implantation, the closest fit carrier having an available carrier configuration, and:

in response to determining, based on a comparison of that the available carrier configuration with the desired carrier configuration, that the closest fit carrier is not satisfactory, generating the first custom carrier using one or more custom carrier components, the one or more custom carrier components including one or more of a 3D printer, injection molding system, machining component, or bioprinter; or

in response to determining, based on a comparison of that the available carrier configuration with the desired carrier configuration, that the closest fit carrier is satisfactory, initiating retrieval of the closest fit carrier without generating the first custom carrier.

17 . The method of claim 16 , further comprising:

selecting a plurality of radioactive seeds having seed strengths indicated in the treatment specifications; and

implanting the plurality of radioactive seeds at positions and orientations indicated in the treatment specifications.

18 . A method comprising:

receiving treatment specifications including at least a tumor cavity size and shape and a radiation dose;

determining a desired carrier configuration based on the treatment specifications, the desired carrier configuration indicating, for a custom carrier, a carrier shape and a radioactive seed quantity;

determining whether a surgery where implantation of the custom carrier will be performed is less than a threshold time period away, and:

in response to determining that the surgery is less than a threshold time period away, determining a closest fit carrier already fabricated and available for implantation, the closest fit carrier having an available carrier configuration closest to the desired carrier configuration, and initiating retrieval of the closest fit carrier; or

in response to determining that the surgery is not less than a threshold time period away, initiating generation of the custom carrier having the desired carrier configuration using one or more custom carrier components, the one or more custom carrier components including one or more of a 3D printer, injection molding system, machining component, or bioprinter.

19 . The method of claim 18 , further comprising:

sterilizing the custom carrier prior to implantation.

20 . The method of claim 18 , further comprising:

selecting a plurality of radioactive seeds having seed strengths indicated in the treatment specifications; and

implanting the plurality of radioactive seeds at positions and orientations indicated in the treatment specifications.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2022
From: COLE, HEIDI; BRACHMAN, DAVID; BAKER, JOHN; TURNER, ADAM
To: GT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 061620/0498 →
Continuity (3)
Provisional Application 63163366 · Mar 19, 2021
Provisional Application 63163583 · Mar 19, 2021
Related Publication 20220296922A1 · Sep 22, 2022
References Cited (355)
US D244393S · Collica et al. · 1977 [cited by applicant]
US 4427005A · Tener · 1984 [cited by applicant]
US 4509506A · Windorski et al. · 1985 [cited by applicant]
US 4697575A · Horowitz · 1987 [cited by applicant]
US 4706652A · Horowitz · 1987 [cited by applicant]
US 4754745A · Horowitz · 1988 [cited by applicant]
US 4946435A · Suthanthiran et al. · 1990 [cited by applicant]
US 5030195A · Nardi · 1991 [cited by applicant]
US 5626592A · Phillips et al. · 1997 [cited by applicant]
US D381080S · Ohata · 1997 [cited by applicant]
US 5772574A · Nanko · 1998 [cited by applicant]
US 5803895A · Kronholz et al. · 1998 [cited by applicant]
US 5840008A · Klein et al. · 1998 [cited by applicant]
US 5871708A · Park et al. · 1999 [cited by applicant]
US D408957S · Sandor · 1999 [cited by applicant]
US 5967966A · Kronholz et al. · 1999 [cited by applicant]
US 5997842A · Chen · 1999 [cited by applicant]
US 6017482A · Anders et al. · 2000 [cited by applicant]
US D420452S · Cardy · 2000 [cited by applicant]
US D420745S · Cardy · 2000 [cited by applicant]
US D420746S · Cardy · 2000 [cited by applicant]
US 6066302A · Bray · 2000 [cited by applicant]
US 6120533A · Fischell · 2000 [cited by applicant]
US 6129670A · Burdette et al. · 2000 [cited by applicant]
US 6193669B1 · Degany et al. · 2001 [cited by applicant]
US D443061S · Bergstrom et al. · 2001 [cited by applicant]
US 6248057B1 · Mavity et al. · 2001 [cited by applicant]
US 6264599B1 · Slater et al. · 2001 [cited by applicant]
US 6273851B1 · Slater et al. · 2001 [cited by applicant]
US 6293899B1 · Sioshansi et al. · 2001 [cited by applicant]
US 6327490B1 · Spetz · 2001 [cited by applicant]
US 6352500B1 · Halpern · 2002 [cited by applicant]
US 6358195B1 · Green et al. · 2002 [cited by applicant]
US 6360116B1 · Jackson et al. · 2002 [cited by applicant]
US 6385477B1 · Werner et al. · 2002 [cited by applicant]
US 6450937B1 · Mercereau et al. · 2002 [cited by applicant]
US 6458069B1 · Tam et al. · 2002 [cited by applicant]
US 6468265B1 · Evans et al. · 2002 [cited by applicant]
US 6471631B1 · Slater et al. · 2002 [cited by applicant]
US 6512943B1 · Kelcz · 2003 [cited by applicant]
US 6539247B2 · Spetz · 2003 [cited by applicant]
US 6547816B1 · O'Foghludha · 2003 [cited by applicant]
US 6572526B1 · Ford · 2003 [cited by applicant]
US 6666811B1 · Good · 2003 [cited by applicant]
US 6679824B1 · Reed et al. · 2004 [cited by applicant]
US 6699170B1 · Crocker et al. · 2004 [cited by applicant]
US 6712508B2 · Nilsson et al. · 2004 [cited by applicant]
US 6712782B2 · Ford · 2004 [cited by applicant]
US D488864S · Fago et al. · 2004 [cited by applicant]
US 6761680B2 · Terwillieger et al. · 2004 [cited by applicant]
US 6770021B2 · Halpern · 2004 [cited by applicant]
US 6787042B2 · Bond et al. · 2004 [cited by applicant]
US 6790170B2 · Moody et al. · 2004 [cited by applicant]
US 6846282B1 · Ford · 2005 [cited by applicant]
US 6971252B2 · Therin et al. · 2005 [cited by applicant]
US 6994688B2 · Brauckman et al. · 2006 [cited by applicant]
US 7011619B1 · Lewis · 2006 [cited by applicant]
US 7070554B2 · White et al. · 2006 [cited by applicant]
US 7118729B1 · O'Foghludha · 2006 [cited by applicant]
US 7171255B2 · Holupka et al. · 2007 [cited by applicant]
US 7190895B1 · Groves et al. · 2007 [cited by applicant]
US D561896S · Jones · 2008 [cited by applicant]
US 7410458B2 · Bray et al. · 2008 [cited by applicant]
US 7442162B2 · Henderson et al. · 2008 [cited by applicant]
US D580056S · Orthner · 2008 [cited by applicant]
US D580057S · Ramadani · 2008 [cited by applicant]
US 7686756B2 · Black et al. · 2010 [cited by applicant]
US 7736293B2 · Lamoureux et al. · 2010 [cited by applicant]
US 7749151B2 · Ferguson · 2010 [cited by applicant]
US 7776310B2 · Kaplan · 2010 [cited by applicant]
US 7972261B2 · Lamoureux et al. · 2011 [cited by applicant]
US 8012455B2 · O'Foghludha · 2011 [cited by applicant]
US 8021291B2 · Lamoureux et al. · 2011 [cited by applicant]
US 8039790B2 · Cho et al. · 2011 [cited by applicant]
US 8097236B2 · Aston et al. · 2012 [cited by applicant]
US 8114007B2 · Lamoureux et al. · 2012 [cited by applicant]
US D657474S · Dona · 2012 [cited by applicant]
US 8187159B2 · Lamoureux et al. · 2012 [cited by applicant]
US 8192345B2 · Lamoureux et al. · 2012 [cited by applicant]
US 8226539B2 · Cutrer · 2012 [cited by applicant]
US 8293630B2 · Dunkley et al. · 2012 [cited by applicant]
US 8323172B2 · Black et al. · 2012 [cited by applicant]
US 8366598B2 · Lamoureux et al. · 2013 [cited by applicant]
US D680649S · Jagger et al. · 2013 [cited by applicant]
US D681210S · Beiriger et al. · 2013 [cited by applicant]
US D681812S · Farris et al. · 2013 [cited by applicant]
US D681813S · Jagger et al. · 2013 [cited by applicant]
US 8454489B2 · Drobnik et al. · 2013 [cited by applicant]
US D686341S · Nakaji et al. · 2013 [cited by applicant]
US D686744S · Nakaji et al. · 2013 [cited by applicant]
US D686745S · Nakaji et al. · 2013 [cited by applicant]
US D686746S · Nakaji et al. · 2013 [cited by applicant]
US D686747S · Nakaji et al. · 2013 [cited by applicant]
US D686748S · Nakaji et al. · 2013 [cited by applicant]
US D687568S · Nakaji et al. · 2013 [cited by applicant]
US D687966S · Nakaji et al. · 2013 [cited by applicant]
US D687967S · Nakaji et al. · 2013 [cited by applicant]
US 8600130B2 · Järliden · 2013 [cited by applicant]
US 8605966B2 · Järliden · 2013 [cited by applicant]
US 8647603B2 · Aston et al. · 2014 [cited by applicant]
US 8771162B2 · Lamoureux et al. · 2014 [cited by applicant]
US 8790235B2 · Lamoureux et al. · 2014 [cited by applicant]
US 8795146B2 · Lamoureux et al. · 2014 [cited by applicant]
US 8825136B2 · Giller et al. · 2014 [cited by applicant]
US 8827884B2 · Ribbing et al. · 2014 [cited by applicant]
US 8834837B2 · Kelson et al. · 2014 [cited by applicant]
US 8876684B1 · Nakaji et al. · 2014 [cited by applicant]
US 8878464B2 · Clayton et al. · 2014 [cited by applicant]
US 8894969B2 · Kelson et al. · 2014 [cited by applicant]
US 8915834B1 · Lamoureux et al. · 2014 [cited by applicant]
US 8939881B2 · Nakaji et al. · 2015 [cited by applicant]
US 8974364B1 · Nakaji et al. · 2015 [cited by applicant]
US 9022914B2 · Clayton et al. · 2015 [cited by applicant]
US 9022915B2 · Nakaji et al. · 2015 [cited by applicant]
US 9180310B2 · Black et al. · 2015 [cited by applicant]
US 9358377B2 · Black et al. · 2016 [cited by applicant]
US 9403033B1 · Brachman · 2016 [cited by applicant]
US 9409038B2 · Nakaji et al. · 2016 [cited by applicant]
US 9492683B2 · Brachman et al. · 2016 [cited by applicant]
US 9526463B2 · Brachman et al. · 2016 [cited by applicant]
US 9545525B2 · Nakaji et al. · 2017 [cited by applicant]
US 9642999B2 · Sutton et al. · 2017 [cited by applicant]
US 9788909B2 · Larkin et al. · 2017 [cited by applicant]
US 9789608B2 · Itkowitz et al. · 2017 [cited by applicant]
US 9808650B2 · White et al. · 2017 [cited by applicant]
US 9821174B1 · Fram et al. · 2017 [cited by applicant]
US 10058713B2 · Kelson et al. · 2018 [cited by applicant]
US 10080909B2 · Brachman et al. · 2018 [cited by applicant]
US 10085699B2 · Brachman et al. · 2018 [cited by applicant]
US 10265542B2 · Brachman et al. · 2019 [cited by applicant]
US 10328278B2 · Krachon et al. · 2019 [cited by applicant]
US 10335613B2 · Dikaiou · 2019 [cited by applicant]
US 10350431B2 · Nakaji et al. · 2019 [cited by applicant]
US 10449386B2 · Bask et al. · 2019 [cited by applicant]
US 10646724B2 · Hoedl et al. · 2020 [cited by applicant]
US 10888710B1 · Brachman et al. · 2021 [cited by applicant]
US 10967198B2 · Herskovic · 2021 [cited by applicant]
US 10974069B2 · Maguire et al. · 2021 [cited by applicant]
US 10981018B2 · Baker et al. · 2021 [cited by applicant]
US 11224761B1 · Wazer et al. · 2022 [cited by applicant]
US 11278736B2 · Brachman et al. · 2022 [cited by applicant]
US 11298846B1 · Hanberg et al. · 2022 [cited by applicant]
US 11413473B2 · Nakaji et al. · 2022 [cited by applicant]
US 11673002B2 · Brachman et al. · 2023 [cited by applicant]
US 12478800B2 · Nakaji et al. · 2025 [cited by applicant]
US 20010044567A1 · Zamora et al. · 2001 [cited by applicant]
US 20010056219A1 · Brauckman et al. · 2001 [cited by applicant]
US 20020055666A1 · Hunter · 2002 [cited by applicant]
US 20020058853A1 · Kaplan · 2002 [cited by applicant]
US 20020058854A1 · Reed et al. · 2002 [cited by applicant]
US 20020103410A1 · Munro, III et al. · 2002 [cited by applicant]
US 20020120174A1 · Steele, Sr. et al. · 2002 [cited by applicant]
US 20020123660A1 · Amols'et al. · 2002 [cited by applicant]
US 20030045769A1 · Kalas et al. · 2003 [cited by applicant]
US 20030088141A1 · Terwilliger et al. · 2003 [cited by applicant]
US 20030088144A1 · Terwilliger et al. · 2003 [cited by applicant]
US 20030092958A1 · Terwilliger et al. · 2003 [cited by applicant]
US 20030109769A1 · Lowery et al. · 2003 [cited by applicant]
US 20030113359A1 · Iyer et al. · 2003 [cited by applicant]
US 20030130573A1 · Yu et al. · 2003 [cited by applicant]
US 20030149329A1 · O'Foghludha · 2003 [cited by applicant]
US 20030153804A1 · Tornes et al. · 2003 [cited by applicant]
US 20030208096A1 · Tam · 2003 [cited by applicant]
US 20040091421A1 · Aston et al. · 2004 [cited by applicant]
US 20040109823A1 · Kaplan · 2004 [cited by applicant]
US 20040116767A1 · Lebovic et al. · 2004 [cited by applicant]
US 20040225176A1 · Flanagan et al. · 2004 [cited by applicant]
US 20040242953A1 · Good · 2004 [cited by applicant]
US 20050035310A1 · Drobnik et al. · 2005 [cited by applicant]
US 20050111621A1 · Riker et al. · 2005 [cited by applicant]
US 20050244045A1 · Eriksson · 2005 [cited by applicant]
US 20050267319A1 · White et al. · 2005 [cited by applicant]
US 20060015030A1 · Poulin et al. · 2006 [cited by applicant]
US 20060058570A1 · Rapach et al. · 2006 [cited by applicant]
US 20060063962A1 · Drobnik et al. · 2006 [cited by applicant]
US 20060100475A1 · White et al. · 2006 [cited by applicant]
US 20060173236A1 · White et al. · 2006 [cited by applicant]
US 20060224035A1 · Russell, Jr. et al. · 2006 [cited by applicant]
US 20060235365A1 · Terwilliger · 2006 [cited by applicant]
US 20060253048A1 · Jones · 2006 [cited by applicant]
US 20070021643A1 · Lamoureux et al. · 2007 [cited by applicant]
US 20070135673A1 · Elliott et al. · 2007 [cited by applicant]
US 20070167665A1 · Hermann et al. · 2007 [cited by applicant]
US 20070190761A1 · Dunkley et al. · 2007 [cited by applicant]
US 20070225544A1 · Vance et al. · 2007 [cited by applicant]
US 20070270627A1 · Cutrer et al. · 2007 [cited by applicant]
US 20080004714A1 · Lieberman · 2008 [cited by applicant]
US 20080009661A1 · Lamoureux et al. · 2008 [cited by applicant]
US 20080058579A1 · Hunter et al. · 2008 [cited by applicant]
US 20080058580A1 · Black et al. · 2008 [cited by applicant]
US 20080071132A1 · Lamoureux et al. · 2008 [cited by applicant]
US 20080146861A1 · Murphy et al. · 2008 [cited by applicant]
US 20080207997A1 · Higgins et al. · 2008 [cited by applicant]
US 20080221384A1 · Chi Sing et al. · 2008 [cited by applicant]
US 20090012347A1 · Helle · 2009 [cited by applicant]
US 20090069625A1 · Helle et al. · 2009 [cited by applicant]
US 20090131734A1 · Neustadter et al. · 2009 [cited by applicant]
US 20090131735A1 · Drobnik et al. · 2009 [cited by applicant]
US 20090136422A1 · Kelson et al. · 2009 [cited by applicant]
US 20090156880A1 · Allan et al. · 2009 [cited by applicant]
US 20090234177A1 · Lebovic et al. · 2009 [cited by applicant]
US 20090253950A1 · Rapach et al. · 2009 [cited by applicant]
US 20090271715A1 · Tumuluri · 2009 [cited by applicant]
US 20090275793A1 · Black et al. · 2009 [cited by applicant]
US 20090326314A1 · Cutrer et al. · 2009 [cited by applicant]
US 20100015042A1 · Keisari et al. · 2010 [cited by applicant]
US 20100056843A1 · Fisher et al. · 2010 [cited by applicant]
US 20100056844A1 · Fisher et al. · 2010 [cited by applicant]
US 20100056908A1 · Giller et al. · 2010 [cited by applicant]
US 20100200778A1 · Drobnik et al. · 2010 [cited by applicant]
US 20100210892A1 · Lamoureaux et al. · 2010 [cited by applicant]
US 20100228074A1 · Drobnik et al. · 2010 [cited by applicant]
US 20100268015A1 · Drobnik et al. · 2010 [cited by applicant]
US 20100280374A1 · Roberts et al. · 2010 [cited by applicant]
US 20100288916A1 · Cho et al. · 2010 [cited by applicant]
US 20100324353A1 · Helle · 2010 [cited by applicant]
US 20110013818A1 · Eriksson Järliden · 2011 [cited by applicant]
US 20110054235A1 · Drobnik et al. · 2011 [cited by applicant]
US 20110206252A1 · Eriksson Järliden · 2011 [cited by applicant]
US 20110224494A1 · Piskun et al. · 2011 [cited by applicant]
US 20120108882A1 · Hoedl · 2012 [cited by applicant]
US 20120165957A1 · Everland et al. · 2012 [cited by applicant]
US 20130102832A1 · Hoedl et al. · 2013 [cited by applicant]
US 20130102891A1 · Binnekamp et al. · 2013 [cited by applicant]
US 20130131434A1 · Nakaji et al. · 2013 [cited by applicant]
US 20130209965A1 · Fisker · 2013 [cited by applicant]
US 20130338423A1 · Nakaji et al. · 2013 [cited by applicant]
US 20140275715A1 · Brachman · 2014 [cited by examiner]
US 20140296612A1 · Schwartz · 2014 [cited by applicant]
US 20140316187A1 · Nakaji et al. · 2014 [cited by applicant]
US 20150057487A1 · Nakaji et al. · 2015 [cited by applicant]
US 20150105605A1 · Finger et al. · 2015 [cited by applicant]
US 20150140535A1 · Geri et al. · 2015 [cited by applicant]
US 20150157879A1 · Wu et al. · 2015 [cited by applicant]
US 20150196778A1 · Nakaji et al. · 2015 [cited by applicant]
US 20150321024A1 · Nakaji et al. · 2015 [cited by applicant]
US 20150367144A1 · Flynn et al. · 2015 [cited by applicant]
US 20150375012A1 · Herskovic · 2015 [cited by applicant]
US 20160242855A1 · Fichtinger et al. · 2016 [cited by applicant]
US 20160367709A1 · Aston et al. · 2016 [cited by applicant]
US 20170021191A1 · Brachman et al. · 2017 [cited by applicant]
US 20170113064A1 · Hingston et al. · 2017 [cited by applicant]
US 20170120073A1 · Brachman et al. · 2017 [cited by applicant]
US 20170209601A1 · Kumar et al. · 2017 [cited by applicant]
US 20170215824A1 · Brachman et al. · 2017 [cited by applicant]
US 20170252575A1 · Nakaji et al. · 2017 [cited by applicant]
US 20180063386A1 · Sharma et al. · 2018 [cited by applicant]
US 20180333509A1 · Aston et al. · 2018 [cited by applicant]
US 20180345038A1 · Kelson et al. · 2018 [cited by applicant]
US 20190018148A1 · Ueno et al. · 2019 [cited by applicant]
US 20190143143A1 · Abdalla · 2019 [cited by applicant]
US 20190240504A1 · Brachman et al. · 2019 [cited by applicant]
US 20200047001A1 · Nakaji et al. · 2020 [cited by applicant]
US 20200086141A1 · Finger et al. · 2020 [cited by applicant]
US 20200206372A1 · Aston et al. · 2020 [cited by applicant]
US 20200261740A1 · Baker et al. · 2020 [cited by applicant]
US 20200261741A1 · Herskovic · 2020 [cited by applicant]
US 20200406059A1 · Kelson et al. · 2020 [cited by applicant]
US 20210008233A1 · Kelson et al. · 2021 [cited by applicant]
US 20210128945A1 · Schmidt et al. · 2021 [cited by applicant]
US 20210154340A1 · Kelson et al. · 2021 [cited by applicant]
US 20210183492A1 · Park · 2021 [cited by applicant]
US 20210236850A1 · Baker et al. · 2021 [cited by applicant]
US 20210353960A1 · Sienko et al. · 2021 [cited by applicant]
US 20210370083A1 · Giladi et al. · 2021 [cited by applicant]
US 20210379096A1 · Domankevich et al. · 2021 [cited by applicant]
US 20220096854A1 · Carlson · 2022 [cited by applicant]
US 20220184418A1 · Arazi et al. · 2022 [cited by applicant]
US 20220212035A1 · Kelson et al. · 2022 [cited by applicant]
US 20220296738A1 · Brachman et al. · 2022 [cited by applicant]
US 20220347489A1 · Brachman et al. · 2022 [cited by applicant]
US 20230012418A1 · Nakaji et al. · 2023 [cited by applicant]
US 20230211176A1 · Brachman et al. · 2023 [cited by applicant]
US 20230218925A1 · Nakaji et al. · 2023 [cited by applicant]
US 20240066318A1 · Brachman et al. · 2024 [cited by applicant]
BR 1120130278412 · 2012 [cited by applicant]
CA 2835065 · 2018 [cited by applicant]
CA 2834559 · 2018 [cited by applicant]
CA 3017174 · 2020 [cited by applicant]
DE 613528 · 1935 [cited by applicant]
EP 0292630B1 · 1995 [cited by applicant]
EP 0906769A2 · 1999 [cited by applicant]
EP 1330292 · 2003 [cited by applicant]
EP 1486230 · 2004 [cited by applicant]
EP 2968884 · 2016 [cited by applicant]
EP 2701803B1 · 2018 [cited by applicant]
EP 3456384 · 2019 [cited by applicant]
JP S529424 · 1975 [cited by applicant]
JP H09028810 · 1997 [cited by applicant]
JP 2001266903 · 2001 [cited by applicant]
JP 3095304 · 2003 [cited by applicant]
JP 2003533301 · 2003 [cited by applicant]
JP 2007512112 · 2007 [cited by applicant]
JP 2009515603 · 2009 [cited by applicant]
JP 2010536529 · 2010 [cited by applicant]
JP 6365983 · 2018 [cited by applicant]
WO WO0187418 · 2001 [cited by applicant]
WO WO2007106531A1 · 2007 [cited by applicant]
WO WO2012100206A2 · 2012 [cited by applicant]
WO WO2012149580A1 · 2012 [cited by applicant]
WO WO2012154988A2 · 2012 [cited by applicant]
WO WO2016171961 · 2016 [cited by applicant]
WO WO2016179420 · 2016 [cited by applicant]
WO WO2017070147 · 2017 [cited by applicant]
WO WO2022198100A1 · 2022 [cited by applicant]
WO WO2023129972A1 · 2023 [cited by applicant]
WO WO2023164585A1 · 2023 [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2024/059030 dated Jan. 22, 2025; 10 pages. [cited by applicant]
Zhou et al., “Review of advanced catheter technologies in radiation oncology brachytherapy procedures,” Cancer Management and Research, 2015: 7, pp. 199-211, Jul. 16, 2015; 13 pages. [cited by applicant]
Extended European Search Report for Application No. 22772318.6 dated Dec. 3, 2024; 10 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/US2022/082483, dated Apr. 26, 2023, in 7 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/US2022/021033, dated Jun. 30, 2022, in 7 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/US2022/021029, dated Jun. 27, 2022, in 9 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/US2023/063174, dated Jun. 15, 2023, in 8 pages. [cited by applicant]
Cole, P.D., et al., “A comparative long-term assessment of four soft tissue supplements”. Anesthetic Surg J. 31(6). 674-681, 2011. [cited by applicant]
International Search Report; International Application No. PCT/US2012/035907, mailed on Sep. 26, 2012; 3 pages . [cited by applicant]
International Search Report; International Application No. PCT/US2012/035909, mailed on Aug. 30, 2012; 3 pages. [cited by applicant]
Crepeau, R.H., et al., “Image Processing of Imperfect Protein Arrays: Sectioned Crystals and Tubulin Sheets and Rings”. Elec. Microsc. Soc. Amer. Proc. 40:84-87, 1982. [cited by applicant]
Crepeau, R.H., et al., “Reconstruction of imperfectly ordered zinc-induced tubulin sheets using cross- correlation and real space averaging”. Ultramicroscopy, 6, 7-18, 1981. [cited by applicant]
Dagnew, E., et al., “Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience”. Neurosurg Focus. 15; 22(… [cited by applicant]
Delaney, T.F., et al., “Intraoperative dural irradiation by customized 192 iridium and 90 Yttrium brachytherapy plaques”. Int. J. Radiat Oncol Biol Phys. 57(1): 239-245, 2003. [cited by applicant]
Ewersten, et al., “Biopsy Guided by Real-Time Sonography Fused with MRI: A Phantom Study”, American Journal of Roentgenology. 2008; 190: 1672-1674. 10.2214/AJR.07.2587. [cited by applicant]
Gutin, P.H., et al., “A coaxial catheter system for after loading radioactive sources for the interstitial irradiation of brain tumors. Technical note”. J. Neurosurg 56: 734-735, 1982. [cited by applicant]
Gutin, P.H., et al., “Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources”. Neurosurgery 20:938-945, 1987. [cited by applicant]
Hamilton, A.J., et al., “The use of gold foil wrapping for radiation protection of the spinal cord for recurrent tumor therapy”. Int. J. Radiat Oncol Biol Phys. 32(2):507-511, 1995. [cited by applicant]
Hilaris, B.S., et al., “Interstitial irradiation for unresectable carcinoma of the lung”. Ann Thoracic Surg; 20:491-500, 1975. [cited by applicant]
Hilaris, B.S., et al., “Intraoperative radiotherapy in stage I and II lung cancer”. Semin Surg Oncol. 3:22-32, 1987. [cited by applicant]
Huang, K., et al., “Surgical resection and permanent iodine-125 brachytherapy for brain metastases”. J. Neurooncol. 91:83-93, 2009. [cited by applicant]
Jenkins, H.P., et al., “Clinical and experimental observations on the use of a gelatin sponge or foam”. Surg 20:124-132, 1946. [cited by applicant]
Kneschaurek, P. et al.: “Die Flabmethode Zur Intraoperativen Bestrahlung. Öthe Flab-Method for Intraoperative Radiation Therapy”, Strahlentherapie und Oknologie, Urban Und Vogel, Muenchen, DE, vol. 171, No. 2; Feb. 1, 1… [cited by applicant]
Marchese, M.J., et al., “A versatile permanent planar implant technique utilizing iodine-125 seeds imbedded in gelfoam”. Int J Radiat Oncol Biol Phys 10:747-751, 1984. [cited by applicant]
Miller, S., et al., “Advances in the virtual reality interstitial brachytherapy system.” Engineering Solutions for the Next Millenium. 1999 IEEE Canadian Conference on Electrical and Computer Engineering (Cat. No. 99TH8… [cited by applicant]
Murphy, M.K., et al., “Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy”. Med Phy 31(6): 1529-1538, Jun. 2004. [cited by applicant]
Nori, D., et al., “Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small-cell lung cancer with positive margin: A pilot study”. J Surg Oncol. 60:257-261, 1995. [cited by applicant]
Parashar, B., et al., “Cesium-131 permanent seed brachytherapy: Dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff”. Brachytherapy. 10:508-511, 2011. [cited by applicant]
Patel, S., et al., “Permanent iodine-125 interstitial implants for the treatment of recurrent Glioblastoma Multiforme”. Neurosurgery 46 (5) 1123-1128, 2000. [cited by applicant]
Rivard, M.J., “Brachytherapy dosimetry parameters calculated for a 131 Cs source”. Med Phys. 34(2): 754-765, 2007. [cited by applicant]
Rogers, C.L., et al., “Surgery and permanent 125-1 seed paraspinal brachytherapy for malignant tumors with spinal cord compression”. Int. J. Radial Oncol Biol Phys. 54(2): 505-513, 2002. [cited by applicant]
Wernicke, A.G., et al., “Feasibility and safety of Gliasite brachytherapy in the treatment of CNS tumors following neurosurgical resection”. J. Cancer Res Ther. 6(1), 65-74, Jan.-Mar. 2010. [cited by applicant]
CivaSheet; “Precision Therapy Without The Beam”; CivaTech Oncology Inc.; CivaTech; https://civatechoncology.com/professionals/civasheet/2 pages; Accessed on Oct. 2018. [cited by applicant]
CivaSheet; “Precision Therapy Without The Beam”; CivaTech Oncology Inc.; CivaTech; https://civatechoncology.com/products-2/products/; 5 pages; Accessed on Oct. 2018. [cited by applicant]
Aima, Manik et al.; “Dosimetric Characterization of a New Directional Low-Dose Rate Brachytherapy Source”; Department of Medical Physics; Mar. 11, 2018; 32 pages. [cited by applicant]
Rivard, Mark J.; “A Directional Pd Brachytherapy Device: Dosimetric Characterization and Practical Aspects for Clinical Use”; Department of Radiation Oncology; Brachytherapy 16 (2017) pp. 421-432. [cited by applicant]
Office Action dated Apr. 2, 2015; European Patent Application No. 12724426.7; 5 pages. [cited by applicant]
Office Action dated Oct. 30, 2015; European Patent Application No. 12724426.7; 4 pages. [cited by applicant]
Office Action dated Feb. 9, 2016; Japanese Application No. 2014-508190; 7 pages including english translation. [cited by applicant]
International Search Report; International Application No. PCT/US2016/031035; filed May 5, 2016; 15 pages; mailed on Aug. 5, 2016. [cited by applicant]
International Search Report and Written Opinion; International Application No. PCT/US2016/027143, filed Apr. 12, 2016; mailed on Aug. 25, 2016; 7 pages. [cited by applicant]
Decision of Rejection dated Feb. 4, 2016, Japanese Patent Application No. 2014-508190 with English Translation; 4 pages. [cited by applicant]
Search and Examination Report; Application No. P1140/13; Filed on Oct. 24, 2013 (PCT Apr. 30, 2012); 10 pages. [cited by applicant]
Summons to Attend Oral Proceedings dated Aug. 18, 2017; European Application No. 12724426.7; 5 pages. [cited by applicant]
Office Action dated Nov. 2, 2017; European Patent Application No. 12724427.5; 4 pages. [cited by applicant]
Extended European Search Report; Application No. 18186392.9; dated Jan. 7, 2019; 7 pages. [cited by applicant]
Extended European Search Report for Application No. 23760942.5 dated Oct. 27, 2025; 10 pages. [cited by applicant]
Extended European Search Report for Application No. 22917538.5 dated Nov. 11, 2025; 11 pages. [cited by applicant]